Skip to main content
. 2020 Jan 17;180(1):135–146. doi: 10.1007/s10549-020-05524-6

Fig. 1.

Fig. 1

Patient disposition. PD progressive disease, DCIS ductal carcinoma in situ, HER2 human epidermal growth factor receptor 2